Joseph Ciaffoni - Dec 19, 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
President and CEO, Director
Signature
/s/ Colleen Tupper as Attorney-In-Fact For Joseph Ciaffoni
Stock symbol
COLL
Transactions as of
Dec 19, 2022
Transactions value $
-$411,840
Form type
4
Date filed
12/21/2022, 06:28 PM
Previous filing
Dec 5, 2022
Next filing
Dec 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Sale -$26.1K -1.13K -0.42% $23.01 268K Dec 19, 2022 Direct F1, F2
transaction COLL Common Stock Sale -$216K -9.38K -3.5% $23.07 259K Dec 20, 2022 Direct F1, F3
transaction COLL Common Stock Sale -$169K -7.33K -2.84% $23.11 251K Dec 21, 2022 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
F3 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).